Future directions in managing aniridia-associated keratopathy

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Congenital aniridia is a rare genetic disorder affecting the iris.
• Aniridia-associated keratopathy (AAK) is a major complication, leading to corneal opacity and vision loss.
• Current management of AAK is challenging due to variability and risks.

Purpose of the Study:

• To review the current understanding of AAK pathogenesis.
• To explore potential therapeutic strategies for AAK.
• To provide insights for future treatment development.

Main Methods:

• Literature review of AAK pathogenesis and management.
• Analysis of molecular mechanisms underlying AAK.
• Synthesis of current and emerging treatment options.

Main Results:

• AAK involves progressive corneal opacification and vision impairment.
• Understanding molecular pathways is crucial for AAK treatment.
• Multiple therapeutic avenues are being explored.

Conclusions:

• Improved understanding of AAK pathogenesis can guide future therapies.
• Potential treatments include surgical, pharmacological, cell, and gene therapies.
• Further research is needed to develop effective AAK interventions.